Women who’ve gone through menopause and hope that supplemental vitamin D plus calcium might shield them from disease may be disappointed by new data. A follow-up analysis of data from the landmark Women’s Health Initiative trial found the supplement combo lowered a woman’s long-term odds of dying from cancer by 7%. However, it also raised… read on > read on >
Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but the company stopped just short of saying it will definitely pull the drug from the market. The… read on > read on >
Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death. “Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity… read on > read on >
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug’s maker said Friday. “The FDA has informed Lilly it wants to further understand topics related to evaluating the safety and… read on > read on >
Folks worried about becoming flabby in middle age should check out what their parents looked like when they were that age, a new study says. People are six times more likely to become obese in middle age if both their parents were chubby during that time of their lives, according to research to be presented… read on > read on >
Children with “lazy eye” are more likely to become adults facing an array of serious health problems, a new study warns. Kids diagnosed with amblyopia are more likely to develop high blood pressure, obesity and diabetes as adults, researchers found. They also face an increased risk of heart attack, according to findings published March 7… read on > read on >
Ambien, Lunesta, Sonata: Millions of bleary-eyed Americans turn to this class of so-called “Z-drugs” to get restful sleep. But how do these drugs work, and do they come with risks? Experts at the U.S. Food and Drug Administration have issued an advisory to boost awareness about the meds. All of these medications — generically known… read on > read on >
Put down that donut and lay off the pasta: New research finds you’re less sexy after gorging on refined carbs. French researchers presented heterosexual adults with photos of an opposite-sex person who two hours earlier had eaten a breakfast rich in refined carbohydrates. Participants rated the folks in the photos as less attractive compared to… read on > read on >
Nearly a quarter of Labrador retrievers are more likely to be obese due to a genetic “double-whammy,” a new study finds. This gene mutation causes Labradors to both feel hungry all the time and also burn fewer calories, British researchers report. The mutation involves a gene called POMC, which plays a critical role in hunger… read on > read on >
Food allergies are difficult to manage at any age, but college students face complex challenges when it comes to navigating the dangers posed by the possibility of life-threatening anaphylaxis. A recent review published in the Annals of Allergy, Asthma and Immunology, the journal of the American College of Allergy, Asthma and Immunology, examines recent evidence… read on > read on >
